Market Cap 1.97B
Revenue (ttm) 1.18B
Net Income (ttm) 2.05M
EPS (ttm) N/A
PE Ratio 40.57
Forward PE 32.70
Profit Margin 0.17%
Debt to Equity Ratio 0.00
Volume 701,000
Avg Vol 584,812
Day's Range N/A - N/A
Shares Out 45.48M
Stochastic %K 67%
Beta 0.96
Analysts Strong Sell
Price Target $61.28

Company Profile

Omnicell, Inc., together with its subsidiaries, provides healthcare technology in the United States and internationally. It offers hospital and health systems solutions, such as points of care for clinician workflows in patient care areas of the healthcare system; Titan XT, an automated dispensing system; XTExtend, a console swap for its XT cabinets; and Central Pharmacy Dispensing Service for the medication dispensing process. The company also provides Central Med Automation Service for medicat...

Industry: Health Information Services
Sector: Healthcare
Phone: 877 415 9990
Address:
4220 North Freeway, Fort Worth, United States
BillionerOfKing
BillionerOfKing May. 11 at 4:20 PM
$OMCL Current Stock Price: $43.01 Contracts to trade: $45.0 OMCL May 15 2026 Call Entry: $0.50 Exit: $0.81 ROI: 63% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Estimize
Estimize May. 4 at 1:09 PM
Wall St is expecting 0.47 EPS for $OMCL Q2 [Reporting 07/30 BMO] http://www.estimize.com/intro/omcl?chart=historical&metric_name=eps&utm_co
0 · Reply
BearLurker
BearLurker May. 3 at 4:48 AM
$OMCL Healthcare technology company with steady demand; growth depends on adoption and margins
0 · Reply
Charterdi3
Charterdi3 May. 2 at 5:11 PM
$OMCL $UNH $ROK $BTC.X #Mining #Earnings ‼️🔥‼️ Can we get research on the table #Investment terminology 😫😔😛
0 · Reply
souldout
souldout Apr. 29 at 11:55 AM
$OMCL Six months since IPO, MedPal AI (MPAL) is starting to look like the UK’s most interesting healthcare growth story at £14m m/c This is a UK-based, AI-powered digital health company, with Wegovy and Mounjaro licences. https://medpal.clinic/weight-loss $OPRX $LFMD
0 · Reply
Olivia_Strickland
Olivia_Strickland Apr. 28 at 2:43 PM
$OMCL Q1 print landed this morning and the tape's taking it well, +17% to 44.02 on 1.5x avg vol. $2B cap that was -12.5% over 3 months getting the earnings reset bid, healthcare automation story finally landing after a rough quarter. Source: https://tapeboard.com/chart/OMCL
0 · Reply
topstockalerts
topstockalerts Apr. 28 at 2:05 PM
Top Gainers PT2 $SNBR $JSPRW $POM $SANM $OMCL
0 · Reply
Alvi722
Alvi722 Apr. 28 at 1:53 PM
$OMCL could be a good short candidate , dangerous though since low shares. @cubie
1 · Reply
AlphaBull_10M
AlphaBull_10M Apr. 28 at 1:52 PM
Pre market gainers led by $OMCL $DDI $KNSA $AXGN $SEI
0 · Reply
OpenOutcrier
OpenOutcrier Apr. 28 at 12:28 PM
$OMCL (+21.4% pre) Hospital demand helps Omnicell swing from loss to $11M profit https://ooc.bz/l/100173
0 · Reply
Latest News on OMCL
Omnicell price target raised to $55 from $53 at Craig-Hallum

2026-04-29T16:43:00.000Z - 13 days ago

Omnicell price target raised to $55 from $53 at Craig-Hallum


Omnicell price target raised to $70 from $60 at KeyBanc

2026-04-29T11:01:22.000Z - 14 days ago

Omnicell price target raised to $70 from $60 at KeyBanc


Omnicell price target raised to $70 from $60 at KeyBanc

2026-04-28T17:15:43.000Z - 14 days ago

Omnicell price target raised to $70 from $60 at KeyBanc


Omnicell Earnings Call Transcript: Q1 2026

Apr 28, 2026, 8:30 AM EDT - 14 days ago

Omnicell Earnings Call Transcript: Q1 2026


Omnicell reports Q1 adjusted EPS 55c, consensus 33c

2026-04-28T10:46:03.000Z - 15 days ago

Omnicell reports Q1 adjusted EPS 55c, consensus 33c


Omnicell sees Q2 adjusted EPS 40c-48c, consensus 42c

2026-04-28T10:45:51.000Z - 15 days ago

Omnicell sees Q2 adjusted EPS 40c-48c, consensus 42c


Omnicell Announces First Quarter 2026 Financial Results

Apr 28, 2026, 6:30 AM EDT - 15 days ago

Omnicell Announces First Quarter 2026 Financial Results


Omnicell management to meet with Piper Sandler

2026-03-11T17:35:14.000Z - 2 months ago

Omnicell management to meet with Piper Sandler


Omnicell management to meet virtually with Benchmark

2026-03-10T15:30:33.000Z - 2 months ago

Omnicell management to meet virtually with Benchmark


Omnicell price target lowered to $49 from $63 at Piper Sandler

2026-02-06T12:01:29.000Z - 3 months ago

Omnicell price target lowered to $49 from $63 at Piper Sandler


Omnicell Earnings Call Transcript: Q4 2025

Feb 5, 2026, 8:30 AM EST - 3 months ago

Omnicell Earnings Call Transcript: Q4 2025


Omnicell reports Q4 adjusted EPS 40c, consensus 50c

2026-02-05T11:42:20.000Z - 3 months ago

Omnicell reports Q4 adjusted EPS 40c, consensus 50c


Omnicell sees Q1 adjusted EPS 26c-36c, consensus 27c

2026-02-05T11:41:57.000Z - 3 months ago

Omnicell sees Q1 adjusted EPS 26c-36c, consensus 27c


Omnicell sees FY26 adjusted EPS $1.65-$1.85, consensus $1.88

2026-02-05T11:41:17.000Z - 3 months ago

Omnicell sees FY26 adjusted EPS $1.65-$1.85, consensus $1.88


Omnicell management to meet with Piper Sandler

2026-02-04T21:17:55.000Z - 3 months ago

Omnicell management to meet with Piper Sandler


Omnicell upgraded to Buy at BofA on new product cycle

2026-02-04T11:20:43.000Z - 3 months ago

Omnicell upgraded to Buy at BofA on new product cycle


Omnicell upgraded to Buy from Neutral at BofA

2026-02-04T11:11:19.000Z - 3 months ago

Omnicell upgraded to Buy from Neutral at BofA


Omnicell price target raised to $60 from $50 at Benchmark

2026-02-02T12:25:44.000Z - 3 months ago

Omnicell price target raised to $60 from $50 at Benchmark


Omnicell upgraded to Overweight from Sector Weight at KeyBanc

2026-01-07T22:50:15.000Z - 4 months ago

Omnicell upgraded to Overweight from Sector Weight at KeyBanc


Omnicell price target raised to $52 from $43 at Wells Fargo

2026-01-05T13:10:20.000Z - 4 months ago

Omnicell price target raised to $52 from $43 at Wells Fargo


Omnicell Transcript: Investor Update

Dec 8, 2025, 7:00 PM EST - 5 months ago

Omnicell Transcript: Investor Update


Omnicell Earnings Call Transcript: Q3 2025

Oct 30, 2025, 8:30 AM EDT - 6 months ago

Omnicell Earnings Call Transcript: Q3 2025


Omnicell Announces Third Quarter 2025 Financial Results

Oct 30, 2025, 6:30 AM EDT - 6 months ago

Omnicell Announces Third Quarter 2025 Financial Results


Omnicell Earnings Call Transcript: Q2 2025

Jul 31, 2025, 8:30 AM EDT - 10 months ago

Omnicell Earnings Call Transcript: Q2 2025


Omnicell Announces Second Quarter 2025 Results

Jul 31, 2025, 6:30 AM EDT - 10 months ago

Omnicell Announces Second Quarter 2025 Results


Omnicell Opens New Innovation Lab in Austin, Texas

May 14, 2025, 8:30 AM EDT - 1 year ago

Omnicell Opens New Innovation Lab in Austin, Texas


Omnicell Earnings Call Transcript: Q1 2025

May 6, 2025, 8:30 AM EDT - 1 year ago

Omnicell Earnings Call Transcript: Q1 2025


Omnicell Announces First Quarter 2025 Results

May 6, 2025, 6:30 AM EDT - 1 year ago

Omnicell Announces First Quarter 2025 Results


Omnicell Announces Chief Financial Officer Transition

Mar 12, 2025, 8:30 AM EDT - 1 year ago

Omnicell Announces Chief Financial Officer Transition


Omnicell Earnings Call Transcript: Q4 2024

Feb 6, 2025, 8:30 AM EST - 1 year ago

Omnicell Earnings Call Transcript: Q4 2024


Omnicell Announces OmniSphere

Dec 9, 2024, 8:30 AM EST - 1 year ago

Omnicell Announces OmniSphere


Omnicell Earnings Call Transcript: Q3 2024

Oct 30, 2024, 8:30 AM EDT - 1 year ago

Omnicell Earnings Call Transcript: Q3 2024


Omnicell Announces Third Quarter 2024 Results

Oct 30, 2024, 6:30 AM EDT - 1 year ago

Omnicell Announces Third Quarter 2024 Results


Omnicell Transcript: 2024 Wells Fargo Healthcare Conference

Sep 5, 2024, 1:30 PM EDT - 1 year ago

Omnicell Transcript: 2024 Wells Fargo Healthcare Conference


Omnicell Announces Central Med Automation Service

Aug 20, 2024, 4:30 PM EDT - 1 year ago

Omnicell Announces Central Med Automation Service


Omnicell Earnings Call Transcript: Q2 2024

Aug 1, 2024, 8:30 AM EDT - 1 year ago

Omnicell Earnings Call Transcript: Q2 2024


Omnicell Announces Second Quarter 2024 Results

Aug 1, 2024, 6:30 AM EDT - 1 year ago

Omnicell Announces Second Quarter 2024 Results


Omnicell Earnings Call Transcript: Q1 2024

May 2, 2024, 8:30 AM EDT - 2 years ago

Omnicell Earnings Call Transcript: Q1 2024


Omnicell Announces First Quarter 2024 Results

May 2, 2024, 7:30 AM EDT - 2 years ago

Omnicell Announces First Quarter 2024 Results


Omnicell Announces XT Amplify

Apr 16, 2024, 4:01 PM EDT - 2 years ago

Omnicell Announces XT Amplify


Omnicell Earnings Call Transcript: Q4 2023

Feb 8, 2024, 8:30 AM EST - 2 years ago

Omnicell Earnings Call Transcript: Q4 2023


Omnicell Elects Eileen Voynick to Board of Directors

Jan 11, 2024, 4:00 PM EST - 2 years ago

Omnicell Elects Eileen Voynick to Board of Directors


Omnicell Earnings Call Transcript: Q3 2023

Nov 2, 2023, 8:30 AM EDT - 2 years ago

Omnicell Earnings Call Transcript: Q3 2023


BillionerOfKing
BillionerOfKing May. 11 at 4:20 PM
$OMCL Current Stock Price: $43.01 Contracts to trade: $45.0 OMCL May 15 2026 Call Entry: $0.50 Exit: $0.81 ROI: 63% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
Estimize
Estimize May. 4 at 1:09 PM
Wall St is expecting 0.47 EPS for $OMCL Q2 [Reporting 07/30 BMO] http://www.estimize.com/intro/omcl?chart=historical&metric_name=eps&utm_co
0 · Reply
BearLurker
BearLurker May. 3 at 4:48 AM
$OMCL Healthcare technology company with steady demand; growth depends on adoption and margins
0 · Reply
Charterdi3
Charterdi3 May. 2 at 5:11 PM
$OMCL $UNH $ROK $BTC.X #Mining #Earnings ‼️🔥‼️ Can we get research on the table #Investment terminology 😫😔😛
0 · Reply
souldout
souldout Apr. 29 at 11:55 AM
$OMCL Six months since IPO, MedPal AI (MPAL) is starting to look like the UK’s most interesting healthcare growth story at £14m m/c This is a UK-based, AI-powered digital health company, with Wegovy and Mounjaro licences. https://medpal.clinic/weight-loss $OPRX $LFMD
0 · Reply
Olivia_Strickland
Olivia_Strickland Apr. 28 at 2:43 PM
$OMCL Q1 print landed this morning and the tape's taking it well, +17% to 44.02 on 1.5x avg vol. $2B cap that was -12.5% over 3 months getting the earnings reset bid, healthcare automation story finally landing after a rough quarter. Source: https://tapeboard.com/chart/OMCL
0 · Reply
topstockalerts
topstockalerts Apr. 28 at 2:05 PM
Top Gainers PT2 $SNBR $JSPRW $POM $SANM $OMCL
0 · Reply
Alvi722
Alvi722 Apr. 28 at 1:53 PM
$OMCL could be a good short candidate , dangerous though since low shares. @cubie
1 · Reply
AlphaBull_10M
AlphaBull_10M Apr. 28 at 1:52 PM
Pre market gainers led by $OMCL $DDI $KNSA $AXGN $SEI
0 · Reply
OpenOutcrier
OpenOutcrier Apr. 28 at 12:28 PM
$OMCL (+21.4% pre) Hospital demand helps Omnicell swing from loss to $11M profit https://ooc.bz/l/100173
0 · Reply
topstockalerts
topstockalerts Apr. 28 at 12:15 PM
Pre Market Top Gainers $SAFX $KIDZ $DRCT $SKYQ $OMCL
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Apr. 28 at 10:43 AM
$OMCL Q1 '26 Earnings Results & Recap • Reported GAAP EPS of $0.25 up 266.67% YoY • Reported revenue of $309.88M up 14.91% YoY • Omnicell is increasing its full year 2026 non-GAAP EBITDA guidance to $153 million to $168 million and non-GAAP earnings per share to $1.80 to $2.00, with total revenues projected between $1.215 billion and $1.255 billion.
0 · Reply
NetworkNewsWire
NetworkNewsWire Apr. 7 at 1:37 PM
AI-Driven Compliance Gamechanger in Pharma Manufacturing and Regulatory Standards $OTLC $NVDA $AMZN $HON $OMCL https://ibn.fm/t6O0q
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Mar. 24 at 2:02 PM
$OMCL RSI: 20.25, MACD: -2.2596 Vol: 3.54, MA20: 37.75, MA50: 41.92 ⚪ HOLD - Sideways 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Feb. 25 at 9:58 PM
$OMCL RSI: 37.96, MACD: -1.8222 Vol: 4.74, MA20: 41.31, MA50: 45.24 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
BillionerOfKing
BillionerOfKing Feb. 20 at 12:25 AM
$OMCL Current Stock Price: $38.62 Contracts to trade: $40.0 OMCL Feb 20 2026 Call Entry: $0.07 Exit: $0.11 ROI: 57% Hold ~20 days Shared as daily free alerts and for educational purposes only. https://dailypickai.com/freealerts
0 · Reply
SuperGreenToday
SuperGreenToday Feb. 16 at 5:43 PM
$OMCL Share Price: $36.49 Contract Selected: Aug 21, 2026 $35 Calls Buy Zone: $4.59 – $5.67 Target Zone: $8.63 – $10.54 Potential Upside: 78% ROI Time to Expiration: 185 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
StocktwitsEarnings
StocktwitsEarnings Feb. 5 at 11:39 AM
$OMCL Q4 '25 Earnings Results & Recap • Reported GAAP EPS of -$0.05 down -114.71% YoY • Reported revenue of $313.98M up 2.32% YoY • Omnicell expects 2026 total revenues to range from $1.22B to $1.26B, with Non-GAAP EBITDA projected between $145M and $160M, and Non-GAAP EPS between $1.65 and $1.85.
0 · Reply
IN0V8
IN0V8 Feb. 4 at 7:47 PM
$OMCL Buy BofA Global Research raises price objective to $70 from $53 BofA Global Research raises to buy from neutral
0 · Reply
TradeMechanics_
TradeMechanics_ Feb. 4 at 6:35 PM
BofA Securities upgraded $OMCL to Buy from Neutral and raised its price target to $70 from $53. The call is driven by expectations of an upside revision cycle from the launch of Omnicell’s new Titan XT automated dispensing cabinet, its first major cabinet refresh since 2017. BofA notes the Street is modeling only 3–4% connected-device revenue CAGR through 2028, versus mid-teens growth in the prior cycle. Shares trade at <13x near-trough 2026 EBITDA versus a 10-year average of ~16x. BofA’s 2027/2028 revenue and EBITDA estimates are 8% and 23% above consensus. While 2026 is seen as a transition year and initial guidance may be conservative, BofA views any weakness as a buying opportunity.
0 · Reply
MagnetarMarkets
MagnetarMarkets Feb. 4 at 10:04 AM
$OMCL healthcare software, medication management
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Jan. 27 at 1:59 PM
$OMCL RSI: 65.98, MACD: 1.9942 Vol: 2.29, MA20: 48.90, MA50: 43.65 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply